Evaluating Pacing Dependency After Aortic Valve Replacement
Pacing Dependence at 1 Year Follow-up in Patients Implanted With a Pacemaker After TAVR: a Multicenter Observational Study.
University Hospital, Montpellier · NCT06756282
This study looks at patients who had a heart valve replacement and got a pacemaker to see how well the pacemaker works a year later and what types of heart issues they have.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 90 (estimated) |
| Sex | All |
| Sponsor | University Hospital, Montpellier (other) |
| Locations | 1 site (Montpellier) |
| Trial ID | NCT06756282 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on patients who have undergone transcatheter aortic valve replacement (TAVR) and subsequently received a permanent pacemaker. It aims to assess the prevalence of effective pacemaker stimulation one year after implantation, as well as three months post-procedure. The study will also analyze the types of conductive disorders associated with the need for pacing and the characteristics of patients who are or are not dependent on stimulation. The findings could provide insights into the long-term management of patients with high-grade conductive disorders following TAVR.
Who should consider this trial
Good fit: Ideal candidates include adults over 18 who require a permanent pacemaker after undergoing TAVR.
Not a fit: Patients who already have a pacemaker prior to TAVR will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could help identify patients who may not need long-term pacing, potentially reducing unnecessary interventions.
How similar studies have performed: While some studies have explored pacing dependency post-TAVR, this specific focus on long-term outcomes is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: all patients who need a permanent pacemaker implantation after TAVR Exclusion Criteria: Patients who have already a pace maker before TAVR
Where this trial is running
Montpellier
- University Hospital of Montpellier — Montpellier, France (RECRUITING)
Study contacts
- Study coordinator: Florence Leclercq, PUPH
- Email: f-leclercq@chu-montpellier.fr
- Phone: 0467336189
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Patients Above 18 Years, Patient Discharge, Pacing Therapy, Aortic Stenosis, transcatheter aortic valve replacement, permanent pacing, conductive disorders, pacing dependency